Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00825318 · ClinicalTrials.gov registry record · NA
Comparison Study of Daily Ultrafiltration and Twice-weekly Hemodialysis
A NA study, sponsored by Renal Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00825318 is a NA study that has completed, run by Renal Research Institute. The registered enrollment target is 13 participants.
The verdict
NCT00825318, a NA study, has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
In this study, the researchers want to find out how patients who have ultrafiltration (removal of excess fluid) 6 times a week and twice-weekly dialysis (removal of excess fluid and waste products) do in terms of their blood pressure and weight. The researchers believe that maintaining patients at their estimated target weight throughout the week using daily ultrafiltration will reduce their blood pressure to levels shown in other similar studies. Such a reduction in blood pressure may reduce the incidence of cerebral vascular disease, peripheral vascular disease, coronary artery disease, and congestive heart failure. The researchers also believe that patients' quality of life will improve while they are undergoing daily ultrafiltration. Studies show that more frequent dialysis treatments result in fewer symptoms for patients. The patients feel better and avoid the weight gains and symptoms that patients have on three times a week dialysis. In addition, their blood lab results are better controlled, requiring less medication.
Interventions
- PROCEDURE Ultrafiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00825318
The ClinicalTrials.gov registry entry for NCT00825318 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renal Research Institute, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrafiltration is the first listed.
NCT00825318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00825318 about?
NCT00825318 is a clinical study titled "Comparison Study of Daily Ultrafiltration and Twice-weekly Hemodialysis". In this study, the researchers want to find out how patients who have ultrafiltration (removal of excess fluid) 6 times a week and twice-weekly dialysis (removal of excess fluid and waste products) do in terms of their blood pressure and weight. The researchers believe that maintaining patients at t...
What is the current status of trial NCT00825318?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2009-07. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00825318?
The interventions under investigation include: Ultrafiltration (PROCEDURE).
Who is sponsoring clinical trial NCT00825318?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.